Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Acarbose was effective in main...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Acarbose was effective in maintaining glycemic control in type 2 diabetes mellitus but was associated with adverse effects

Acarbose was effective in maintaining glycemic control in type 2 diabetes mellitus but was associated with adverse effects

Bibliographic Details
Main Authors: Holman, R, Dinneen, S
Format: Journal article
Language:English
Published: 1999
  • Holdings
  • Description
  • Similar Items
  • Staff View
Description
Summary:

Similar Items

  • The effect of combination therapy of sulfonylurea, metformin, and acarbose in type 2 diabetes mellitus patients
    by: Tri Murti Andayani,, et al.
    Published: (2009-12-01)
  • A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
    by: Holman, R, et al.
    Published: (1999)
  • Effects of the addition of acarbose to insulin and non-insulin regimens in veterans with type 2 diabetes mellitus
    by: Wettergreen SA, et al.
    Published: (2016-12-01)
  • Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters
    by: P. Rosenbaum, et al.
    Published: (2002-08-01)
  • Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus
    by: Hui Fang, et al.
    Published: (2020-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs